Coronary artery disease and haemostatic variables in heterozygous familial hypercholesterolaemia.

D D Sugrue, I Trayner, G R Thompson, V J Vere, J Dimeson, Y Stirling, T W Meade

Haemostatic variables were measured in 61 patients with heterozygous familial hypercholesterolaemia, 32 of whom had evidence of coronary heart disease. Age adjusted mean concentrations of plasma fibrinogen and factor VIII were significantly higher in these patients than in the 29 patients without coronary heart disease, but there were no significant differences in serum lipid concentrations between the two groups. Comparisons in 30 patients taking and not taking lipid lowering drugs showed lower values for low density lipoprotein cholesterol, high density lipoprotein cholesterol and antithrombin III, and a higher high density lipoprotein ratio while receiving treatment. The results suggest that hypercoagulability may play a role in the pathogenesis of coronary heart disease in patients with familial hypercholesterolaemia.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Mascitelli, L., Ravnskov, U., Pezzetta, F., Goldstein, M. R. (2009). After the Failure of ENHANCEd Cholesterol Lowering in Familial Hypercholesterolemia, SEAS of Problems with Ezetimibe. ANGIOLOGY 60: 127-128  
• Ravnskov, U., McCully, K. S. (2009). Vulnerable Plaque Formation from Obstruction of Vasa Vasorum by Homocysteinylated and Oxidized Lipoprotein Aggregates Complexed with Microbial Remnants and LDL Autoantibodies. Annals of Clinical & Laboratory Science 39: 3-16 [Abstract] [Full Text]  
• Erol, O., Kara, G., Ozcakar, L., Haznedaroglu, I. C. (2008). Increased Factor VIII Level Lends Diversity to Ischemic Stroke Etiology. CLIN APPL THROMB HEMOST 14: 372-373